Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Revenue

In the year 2024, Prelude Therapeutics had annual revenue of $7.00M. Prelude Therapeutics had revenue of $4.00M in the quarter ending December 31, 2024.

• Revenue (ttm): $7.00M
• Revenue Growth: n/a
• P/S Ratio: 8.90
• Revenue / Employee: $53,435
• Employees: 131
• Market Cap: 44.58M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	7.00M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.